ARC, which had been founded originally as the Empire Rheumatism Council in 1936, changed its name to Arthritis Research UK in 2010 as part of a drive to raise the profile of Arthritis research and the organisation itself. It has also reduced the potential for confusion with a plethora of other charitable groups using the ‘arc’ initials.
The Arthritis Research UK research committee considers around 400 applications for funding per year. The medical research provides answers about the causes of arthritis, effective treatment, and ultimately the cure for all arthritis and musculoskeletal conditions.
Arthritis Research UK has been awarded for:
- Developing anti-TNF therapy for rheumatoid arthritis beyond existing treatments
- Identifying the genes linked to the disease in patients with osteoarthritis
- Developing longer-lasting and durable prostheses, and researching the causes, effects and treatments of infections in joint replacements
- Improving the treatment of brittle bone disease in children
- Developing tissue engineering techniques in osteoarthritis by using patients’ own cartilage
- Looking at ways of better targeting drug treatment in arthritis in children and teenagers
- Examining the role of therapies such as acupuncture and yoga, on osteoarthritis and back pain
Arthritis Research UK research articles from Innovation Toronto
- Body clock study unlocks prospect of treatment for osteoarthritis – December 21, 2015
- Arthritis cure is on the way: Scientists make new breakthrough using embryonic stem cells – March 7, 2015
- New ‘microcapsules’ have potential to repair damage caused by osteoarthritis
- New research claims rheumatoid arthritis breakthrough